Mangoceuticals (NASDAQ:MGRX) Shares Surge Almost Threefold Following Nuclea Agreement; Existing Shareholders Retain 4%
Mangoceuticals shares surged almost threefold on Friday morning following the announcement of a nuclear reverse merger. The stock traded at $0.8029, marking a 173.5% increase from the previous day's close, after touching a high of $1.23 earlier. Trading volume surpassed 350.5 million shares.
